These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 25087362)

  • 1. Hippocratic obligation to shareholder profit? Medical treatment patents and the Australian High Court in Apotex Pty Ltd v Sanofi-Aventis Australia Pty Ltd [2013] HCA 50.
    Vines T
    J Law Med; 2014 Jun; 21(4):797-809. PubMed ID: 25087362
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New forms of evergreening in Australia: misleading advertising, enantiomers and data exclusivity: Apotex v Servier and Alphapharm v Lundbeck.
    Faunce T; Vines T; Gibbons H
    J Law Med; 2008 Oct; 16(2):220-32. PubMed ID: 19010001
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Freedom of information applications as an "evergreening" tactic: Secretary, Department of Health and Ageing v iNOVA Pharmaceuticals (Australia) Pty Ltd (2010) 191 FCR 573; [2010] FCA 1442.
    Vines T; Faunce T
    J Law Med; 2011 Sep; 19(1):43-52. PubMed ID: 21988009
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Balancing public health, trade and intellectual monopoly privileges: recent Australian IP legislation and the TPPA.
    Vines T; Crow K; Faunce T
    J Law Med; 2012 Dec; 20(2):280-94. PubMed ID: 23431847
    [TBL] [Abstract][Full Text] [Related]  

  • 5. AUSTRALIAN COMPETITION AND CONSUMER COMMISSION v PFIZER: EVERGREENING AND MARKET POWER AS A BLOCKBUSTER DRUG GOES OFF PATENT.
    Faunce T
    J Law Med; 2015 Jun; 22(4):771-87. PubMed ID: 26349378
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patents and the obligation to protect health: examining the significance of human rights considerations in the protection of pharmaceutical patents.
    Owoeye OA
    J Law Med; 2014 Jun; 21(4):900-19. PubMed ID: 25087369
    [TBL] [Abstract][Full Text] [Related]  

  • 7. How are pharmaceutical patent term extensions justified? Australia's evolving scheme.
    Lawson C
    J Law Med; 2013 Dec; 21(2):379-98. PubMed ID: 24597388
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Vioxx pharmaceutical scandal: Peterson v Merke Sharpe & Dohme (Aust) Pty Ltd (2010) 184 FCR 1.
    Faunce T; Townsend R; McEwan A
    J Law Med; 2010 Sep; 18(1):38-49. PubMed ID: 20977160
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MYRIAD VOICES AGAINST GENE PATENTS IN THE HIGH COURT.
    McCallum L; Faunce T
    J Law Med; 2015 Dec; 23(2):322-9. PubMed ID: 26939499
    [TBL] [Abstract][Full Text] [Related]  

  • 10. US files WTO complaints against Brazil over requirement for "local working" of patents.
    Elliott R
    Can HIV AIDS Policy Law Rev; 2000; 5(4):28. PubMed ID: 11833162
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Federal court of appeal strikes claim for extending patent term.
    Elliott R
    Can HIV AIDS Policy Law Newsl; 2000; 5(2-3):12-3, 12-4. PubMed ID: 11833188
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmaceutical patents and some international trade issues: Canada, the United States, and NAFTA.
    Tancer RS
    Clin Ther; 1993; 15(6):1177-84; discussion 1120. PubMed ID: 8111813
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trans-Pacific Partnership Provisions in Intellectual Property, Transparency, and Investment Chapters Threaten Access to Medicines in the US and Elsewhere.
    Baker BK
    PLoS Med; 2016 Mar; 13(3):e1001970. PubMed ID: 26954325
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Canadian court upholds Glaxo's patent on AZT.
    Elliott R
    Can HIV AIDS Policy Law Rev; 2001; 6(1-2):53-7. PubMed ID: 11837029
    [TBL] [Abstract][Full Text] [Related]  

  • 15. REGULATION OF AUSTRALIAN MEDICAL PROFESSIONALS AND NATIONAL SECURITY: LESSONS FROM THREE CASE STUDIES.
    Faunce T; McKenna M; Rayner J; Hawes J
    J Law Med; 2016 Mar; 23(3):544-56. PubMed ID: 27323633
    [TBL] [Abstract][Full Text] [Related]  

  • 16. AUSTRALIAN COMPETITION AND CONSUMER COMMISSION v ACN 117 372 915: SHOULD CONSUMER LAW REGULATE DOCTOR-PATIENT RELATIONS IN A CORPORATISED HEALTH CARE SYSTEM?
    Wallace J; Pyman E; Faunce T
    J Law Med; 2015 Sep; 23(1):55-66. PubMed ID: 26554198
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Panel rules against Canada on patent terms for pre-TRIPS patents.
    Elliott R
    Can HIV AIDS Policy Law Newsl; 2000; 5(2-3):43, 45. PubMed ID: 11833196
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Unsettling drug patent settlements: a framework for presumptive illegality.
    Carrier MA
    Mich Law Rev; 2009 Oct; 108(1):37-80. PubMed ID: 20535881
    [TBL] [Abstract][Full Text] [Related]  

  • 19. It is not unethical, though it is often unwise, to override patents.
    Leventer H
    Am J Bioeth; 2002; 2(3):50-1. PubMed ID: 12230860
    [No Abstract]   [Full Text] [Related]  

  • 20. Enhanced scope for extension of patent term for pharmaceuticals under Australian law.
    Lyons M; Stark A
    Pharm Pat Anal; 2015; 4(5):351-5. PubMed ID: 26490425
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.